DELOITTE CONSULTING LLP

Federal contract award, Deloitte, $939,046

Key CONT_AWD_75F40122F19003_7524_75F40122A00001_7524. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 347 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/deloitte/CONT_AWD_75F40122F19003_7524_75F40122A00001_7524

At the source https://www.usaspending.gov/award/CONT_AWD_75F40122F19003_7524_75F40122A00001_7524

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:50:52Z

Content hash be7c819a6198d0759ce1898ee622c1c8f6e0488f737eda8e1091885624e2ca19

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$939,046	first version	July 28, 2022	September 23, 2025	2026-09-05T00:50:52Z	historical sweep	`be7c819a6198`

Archived copy

None on file. An archived copy is optional corroboration and never a condition of this filing’s provenance, which is the stored response and its hash above; see the methodology page.

What the amount is made of

4 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-20, when USAspending reported a total obligation of $939,046.

Action date	Modification	Type	Obligated	Description as recorded
September 23, 2025	P00003	CLOSE OUT	−$442	NEW DRUGS REVIEW PROGRAM (NDRP) KNOWLEDGE MANAGEMENT (KM) CAPABILITIES DEVELOPMENT. - THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.
September 16, 2025	P00002	OTHER ADMINISTRATIVE ACTION	no money	NEW DRUGS REVIEW PROGRAM (NDRP) KNOWLEDGE MANAGEMENT (KM) CAPABILITIES DEVELOPMENT.
May 22, 2023	P00001	SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE	+$249,749	THE PURPOSE OF THIS BILATERAL MODIFICATION TO: A) EXTEND THE PERIOD OF PERFORMANCE END DATE BY SIX (6) MONTHS FROM 05/01/2023 TO 10/30/2023. B) CHANGE THE CONTRACTING OFFICER (CO). THE NEW CO FOR THIS ACTION IS IAN WEISS (IAN.WEISS@FDA.HHS.G
July 28, 2022	base	not on file	+$689,739	NEW DRUGS REVIEW PROGRAM (NDRP) KNOWLEDGE MANAGEMENT (KM) CAPABILITIES DEVELOPMENT.

Last refreshed November 4, 2026 at 2:31 PM UTC.